top of page

Join our email list for e-newsletter, upcoming events & information

Home
About
Learn
Advocate
Connect
Resources
More

Use tab to navigate through the menu items.

< Back

Neuroendocrine Carcinoma (NEC)

Neuroendocrine Carcinoma (NEC)

SWOG S2012: Immunotherapy (Atezolizumab) + Standard Platinum
Systemic VSV-IFNβ-NIS and Pembrolizumab in Refractory NSCLC and NEC

LACNETS
PO BOX 370466
DENVER, CO 80237

info@lacnets.org

TERMS & CONDITIONS

© 2023 by LACNETS

bottom of page